Business Context and Reporting Period
This Form 8-K Current Report was filed by Harvard Bioscience, Inc. on December 17, 2018, covering the event date of December 14, 2018. The filing addresses a specific corporate governance event regarding the departure of a senior executive.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to personnel changes and does not contain financial statements or performance data.
Material Changes
The material change reported is the resignation of Yong Sun, who held the position of Vice President and General Manager of Physiology, Cell and Molecular Instruments. Mr. Sun submitted his resignation on December 14, 2018, to pursue other interests. His departure is effective as of January 4, 2019.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, forward-looking outlook statements, or specific risk factors beyond the operational impact of the executive departure. No unusual items or contingencies were disclosed in this report.
Investor Verification Checklist
- Verify the timeline for the appointment of a successor to the Vice President and General Manager of Physiology, Cell and Molecular Instruments.
- Review subsequent filings to assess the impact of this departure on the Physiology, Cell and Molecular Instruments business segment.
- Confirm if any severance or compensatory arrangements were made for the departing executive, as this is not detailed in the current text.